Schafer Cullen Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $18.1M | Sell |
|
|||||
|
2020
Q3 | $46.1M | Sell |
|
|||||
|
2020
Q2 | $53.9M | Sell |
|
|||||
|
2020
Q1 | $51.6M | Sell |
|
|||||
|
2019
Q4 | $67.8M | Sell |
|
|||||
|
2019
Q3 | $63.8M | Buy |
|
|||||
|
2019
Q2 | $58.8M | Buy |
|
|||||
|
2019
Q1 | $52.6M | Sell |
|
|||||
|
2018
Q4 | $51.2M | Sell |
|
|||||
|
2018
Q3 | $64.1M | Sell |
|
|||||
|
2018
Q2 | $70.7M | Sell |
|
|||||
|
2018
Q1 | $73.1M | Buy |
|
|||||
|
2017
Q4 | $39.9M | Sell |
|
|||||
|
2017
Q3 | $77.1M | Sell |
|
|||||
|
2017
Q2 | $86.1M | Sell |
|
|||||
|
2017
Q1 | $97.2M | Buy |
|
|||||
|
2016
Q4 | $82.8M | Sell |
|
|||||
|
2016
Q3 | $105M | Buy |
|
|||||
|
2016
Q2 | $97.7M | Sell |
|
|||||
|
2016
Q1 | $91.8M | Sell |
|
|||||
|
2015
Q4 | $95.6M | Sell |
|
|||||
|
2015
Q3 | $106M | Sell |
|
|||||
|
2015
Q2 | $116M | Buy |
|
|||||
|
2015
Q1 | $129M | Buy |
|
|||||
|
2014
Q4 | $72M | Sell |
|
|||||
|
2014
Q3 | $134M | Buy |
|
|||||
|
2014
Q2 | $148M | Buy |
|
|||||
|
2014
Q1 | $133M | Buy |
|
|||||
|
2013
Q4 | $112M | Buy |
|
|||||
|
2013
Q3 | $91.4M | Buy |
|
|||||
|
2013
Q2 | $77.4M | Buy |
|